Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
325,254
-
Shares change
-
-27,960
-
Total reported value, excl. options
-
$462,320
-
Value change
-
-$11,088
-
Number of buys
-
4
-
Number of sells
-
2
-
Price
-
$1.42
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2014
As of 30 Jun 2014 IGC Pharma, Inc. - COM NEW (IGC) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 325,254 shares of stock of the company.
Largest 7 holders included WELLS FARGO & COMPANY/MN, Creative Planning, GOLDMAN SACHS GROUP INC, Vantage Investment Advisors, LLC, National Asset Management, Inc., UBS AG, and Citadel Advisors LLC.
This table shows 7 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.